Sanuwave Says PACE Technology Shows Promise for Bone Tissue Engineering

Sanuwave’s Pulsed Acoustic Cellular Expression technology is showing promise in pre-clinical research to create autogenous sources of stem cells for bone tissue engineering, according to a release from Sanuwave.

Advertisement

Results so far support the proposition that PACE could be used to cause proliferation and thickening of the cambium layer of the femur’s periosteum for intraoperative harvesting of progenitor stem cells for bone or cartilage regeneration.

Read Sanuwave’s release on Pulsed Acoustic Cellular Expression (pdf).

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.